MaaT Pharma SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 2.23 million compared to EUR 1.43 million a year ago. Net loss was EUR 19.72 million compared to EUR 13.71 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 EUR | -0.64% | +6.41% | +33.24% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.24% | 116M | |
-3.12% | 102B | |
+1.69% | 96.29B | |
+2.13% | 22.18B | |
-15.72% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.10% | 16.36B | |
+5.11% | 13.97B | |
+32.78% | 12.17B |
- Stock Market
- Equities
- MAAT Stock
- News MaaT Pharma
- MaaT Pharma SA Reports Earnings Results for the Full Year Ended December 31, 2023